Additional file 1: of Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury

Figure S1. Western blot analysis for Akt and ERK1/2 phosphorylation level in neonatal rat cardiomyocytes (NRCMs) treated with Akt or MEK inhibitor. (a) NRCMs were treated with Akt inhibitor MK2206 (10 nM, 24 h) or control under the condition of oxygen glucose deprivation/reperfusion (OGDR) (n = 3). (b) NRCMs were treated with MEK inhibitor PD98059 (50 μM, 24 h) or control under the condition of OGDR (n = 3). All membranes were probed, stripped, and then reprobed for determining the phosphorylation levels of Akt and ERK1/2. Data were expressed as mean ± SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001. (PDF 148 kb)